HEPATOBILIARY NEOPLASM

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting HEPATOBILIARY NEOPLASM:

# Drug Count
0 ADALIMUMAB 3
1 SITAGLIPTIN 2
2 AMPHOTERICIN B 1
3 BASILIXIMAB 1
4 BLINATUMOMAB 1
5 CABAZITAXEL 1
6 CALCITRIOL 1
7 CALCITRIOL CAPSULES 0.25 MCG 1
8 CALCITRIOL CAPSULES 0.5 MCG 1
9 CYCLOSPORINE 1
See all common drugs associated with HEPATOBILIARY NEOPLASM

HEPATOBILIARY NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEBENTAFUSP 1 0.0017
1 MOSUNETUZUMAB 1 0.0009
2 GLOFITAMAB 1 0.0004
3 CABAZITAXEL 1 0.0003
4 BLINATUMOMAB 1 0.0001
5 BASILIXIMAB 1 0.0001
6 AMPHOTERICIN B 1 0.0001
7 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
8 SITAGLIPTIN 2 0.0000
9 CYCLOSPORINE 1 0.0000
See all drugs enriched for association with HEPATOBILIARY NEOPLASM